Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 6/20 | 0.51 |
| ▸ | TYMS | P04818 | 1/20 | 0.46 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | FPR2 | P25090 | 1/20 | 0.38 |
| ▸ | CFTR | P13569 | 1/20 | 0.38 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29581434 | 1.00 | PGR (0.51) | PGRTYMSNOTUMMEN1POLB | |
| SCHEMBL31671044 | 0.88 | PGR (0.42) | PGRTYMSNOTUMMEN1POLB | |
| SCHEMBL9707125 | 0.83 | MAOA (0.59) | PGRTYMSNOTUMMEN1POLB | |
| SCHEMBL30205839 | 0.79 | CYP2A6 (0.39) | PGRTYMSMEN1POLBKMT2A | |
| SCHEMBL1119749 | 0.79 | CYP2A6 (0.39) | PGRTYMSMEN1POLBKMT2A | |
| SCHEMBL20465583 | 0.79 | MEN1 (0.40) | PGRTYMSMEN1POLBKMT2A | |
| SCHEMBL26327483 | 0.79 | TYMS (0.47) | PGRTYMS | |
| SCHEMBL28680129 | 0.78 | POLB (0.54) | PGRTYMSMEN1POLBKMT2A | |
| SCHEMBL4420953 | 0.77 | PGR (0.77) | PGRMEN1KMT2AL3MBTL1 | |
| SCHEMBL23730282 | 0.77 | CFTR (0.41) | PGRTYMSMEN1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 542 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113861113-A | Preparation and application of fused ring pyridine compound and derivative thereof | 中国科学院福建物质结构研究所 | 2021-12-31 | — | — | CN | claimed |
| WO-2016189024-A1 | COSMETIC COMPOSITIONS COMPRISING SCLAREOLIDE | SYMRISE AG (DE) | 2016-12-01 | — | — | WO | claimed |
| EP-1478616-B1 | INDANES AND INDANONES AND THEIR USE IN PERFUMERY | GIVAUDAN SA (CH) | 2010-09-22 | — | — | EP | claimed |
| CN-1329365-C | Indanes and indanones and their use in perfumery | GIVAUDAN SA (CH) | 2007-08-01 | — | — | CN | claimed |
| US-20050148493-A1 | Indanes and indanones and their use in perfumery | FLACHSMANN FELIX (CH) | 2005-07-07 | — | — | US | claimed |
| CN-1615294-A | Indanes and indanones and their use in perfumery | GIVAUDAN SA (CH) | 2005-05-11 | — | — | CN | claimed |
| EP-1478616-A1 | INDANES AND INDANONES AND THEIR USE IN PERFUMERY | Givaudan SA (CH) | 2004-11-24 | — | — | EP | claimed |
| WO-2003072533-A1 | INDANES AND INDANONES AND THEIR USE IN PERFUMERY | GIVAUDAN SA (CH) | 2003-09-04 | — | — | WO | claimed |
| EP-1340741-A1 | Indane derivatives and their use in perfumery | Givaudan SA (CH) | 2003-09-03 | — | — | EP | claimed |
| EP-1184447-A1 | Composition having organoleptic characteristics of Safranal | Givaudan SA (CH) | 2002-03-06 | — | — | EP | claimed |
| EP-0162465-A2 | Novel compounds useful in perfumes | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1985-11-27 | — | — | EP | claimed |
| US-4532357-A | Reacting methylindanes with oxygen or air in presence of transition metal oxidation catalyst, recovering product by fractional distillation | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1985-07-30 | — | — | US | claimed |
| US-12637482-B2 | Compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2026-05-26 | — | — | US | disclosed |
| EP-4263544-B1 | INDOLO[3.2.1-JK]CARBAZOLE-6-CARBONITRILE DERIVATIVES AS BLUE EMITTERS IN OLEDS | UDC IRELAND LTD (IE) | 2026-05-13 | — | — | EP | disclosed |
| US-12628554-B2 | Photoelectric conversion element, imaging element, optical sensor, and compound | FUJIFILM CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| US-12611404-B2 | Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides | CHEMOCENTRYX, INC. (US) | 2026-04-28 | — | — | US | disclosed |
| US-4532357-A | Reacting methylindanes with oxygen or air in presence of transition metal oxidation catalyst, recovering product by fractional distillation | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1985-07-30 | — | — | US | disclosed |
| US-4172093-A | Pharmacodynamically active indan derivatives | AB KABI (SE) | 1979-10-23 | — | — | US | disclosed |
| US-4076726-A | Amidino-hydrazone derivatives | AKZONA INCORPORATED (US) | 1978-02-28 | — | — | US | disclosed |
| US-4028380-A | Hydrazino-imidazole derivatives | AKZONA INCORPORATED (US) | 1977-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12611404-B2 | Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides | CCR1, CCR9, CCR8 | PGR 688/4885TYMS 1974/4885NOTUM 4360/4885 |
| US-20050148493-A1 | Indanes and indanones and their use in perfumery | NISCH, CYP1B1, CYP2E1 | PGR 798/4885TYMS 2114/4885NOTUM 69/4885 |
| US-12637482-B2 | Compound and organic light emitting device comprising same | NR1H2, NR1H3, NR2E3 | PGR 358/4885TYMS 4280/4885NOTUM 3553/4885 |
| US-12628554-B2 | Photoelectric conversion element, imaging element, optical sensor, and compound | SCO2, CRY2, PYM1 | PGR 1290/4885TYMS 4184/4885NOTUM 4548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.